Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Discrepancies in plasma levels of complement components measured by a newly introduced commercially available magnetic bead technique compared to presently available clinical reference intervals.

Sandholm K, Carlsson H, Persson B, Skattum L, Tjernberg I, Nilsson B, Ekdahl KN.

Scand J Immunol. 2019 Sep 19:e12831. doi: 10.1111/sji.12831. [Epub ahead of print]

PMID:
31536648
2.

Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.

Lager M, Dessau RB, Wilhelmsson P, Nyman D, Jensen GF, Matussek A, Lindgren PE, Henningsson AJ; ScandTick Biobank Study Group, Baqir H, Serrander L, Johansson M, Tjernberg I, Skarstein I, Ulvestad E, Grude N, Pedersen AB, Bredberg A, Veflingstad R, Wass L, Aleke J, Nordberg M, Nyberg C, Perander L, Bojesson C, Sjöberg E, Lorentzen ÅR, Eikeland R, Noraas S, Henriksson GA, Petrányi G.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1933-1945. doi: 10.1007/s10096-019-03631-x. Epub 2019 Aug 9.

3.

Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.

Tjernberg I, Johansson M, Henningsson AJ.

Clin Chem Lab Med. 2019 Nov 26;57(12):2008-2018. doi: 10.1515/cclm-2019-0315.

PMID:
31199760
4.

[Patient-initiated diagnostics - a challenge for laboratory medicine].

Simonsson P, Tjernberg I.

Lakartidningen. 2019 Apr 2;116. pii: FIFW. Swedish.

5.

The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.

Henningsson AJ, Lager M, Brännström R, Tjernberg I, Skogman BH.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1983-1991. doi: 10.1007/s10096-018-3334-3. Epub 2018 Aug 6.

6.

Subclinical Lyme borreliosis is common in south-eastern Sweden and may be distinguished from Lyme neuroborreliosis by sex, age and specific immune marker patterns.

Carlsson H, Ekerfelt C, Henningsson AJ, Brudin L, Tjernberg I.

Ticks Tick Borne Dis. 2018 Mar;9(3):742-748. doi: 10.1016/j.ttbdis.2018.02.011. Epub 2018 Feb 16.

PMID:
29502989
7.

Falskt förhöjd kreatininnivå orsakades av M-komponent.

Tjernberg I, Gustafsson I.

Lakartidningen. 2018 Jan 22;115. pii: EWLU. Swedish.

8.

IgE reactivity to α-Gal in relation to Lyme borreliosis.

Tjernberg I, Hamsten C, Apostolovic D, van Hage M.

PLoS One. 2017 Sep 27;12(9):e0185723. doi: 10.1371/journal.pone.0185723. eCollection 2017.

9.

Feto-maternal osmotic balance at term. A prospective observational study.

Moen V, Brudin L, Tjernberg I, Rundgren M, Irestedt L.

J Perinat Med. 2018 Feb 23;46(2):183-189. doi: 10.1515/jpm-2016-0425.

PMID:
28862988
10.

The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.

Skogman BH, Lager M, Henningsson AJ, Tjernberg I.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2221-2229. doi: 10.1007/s10096-017-3049-x. Epub 2017 Jul 20.

11.

Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences.

Johansson M, Manfredsson L, Wistedt A, Serrander L, Tjernberg I.

APMIS. 2017 May;125(5):476-481. doi: 10.1111/apm.12664. Epub 2017 Feb 22.

PMID:
28225145
12.

[Time for laboratory results 2.0].

Tjernberg I.

Lakartidningen. 2017 Jan 23;114. pii: EFDT. Swedish. No abstract available.

13.

Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.

Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I.

APMIS. 2016 Nov;124(11):985-990. doi: 10.1111/apm.12596. Epub 2016 Sep 20.

14.

Human isolates of Listeria monocytogenes in Sweden during half a century (1958-2010).

Lopez-Valladares G, Tham W, Parihar VS, Helmersson S, Andersson B, Ivarsson S, Johansson C, Ringberg H, Tjernberg I, Henriques-Normark B, Danielsson-Tham ML.

Epidemiol Infect. 2014 Nov;142(11):2251-60. doi: 10.1017/S0950268813003385. Epub 2014 Jan 20.

PMID:
24480252
15.

Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.

Henningsson AJ, Christiansson M, Tjernberg I, Löfgren S, Matussek A.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):797-803. doi: 10.1007/s10096-013-2014-6. Epub 2013 Nov 22.

16.

Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.

Henningsson AJ, Tjernberg I, Malmvall BE, Forsberg P, Ernerudh J.

J Neuroinflammation. 2011 Apr 20;8:36. doi: 10.1186/1742-2094-8-36.

17.

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.

Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J.

J Infect. 2011 Feb;62(2):149-58. doi: 10.1016/j.jinf.2010.11.005. Epub 2010 Nov 16.

18.

Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis.

Tjernberg I, Carlsson M, Ernerudh J, Eliasson I, Forsberg P.

BMC Infect Dis. 2010 Feb 5;10:20. doi: 10.1186/1471-2334-10-20.

19.

Description of Acinetobacter venetianus ex Di Cello et al. 1997 sp. nov.

Vaneechoutte M, Nemec A, Musílek M, van der Reijden TJ, van den Barselaar M, Tjernberg I, Calame W, Fani R, De Baere T, Dijkshoorn L.

Int J Syst Evol Microbiol. 2009 Jun;59(Pt 6):1376-81. doi: 10.1099/ijs.0.003541-0.

PMID:
19502319
20.

Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.

Tjernberg I, Sillanpää H, Seppälä I, Eliasson I, Forsberg P, Lahdenne P.

Int J Med Microbiol. 2009 Aug;299(6):439-46. doi: 10.1016/j.ijmm.2008.10.006. Epub 2009 Jan 9.

PMID:
19138558
21.

Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007.

Parihar VS, Lopez-Valladares G, Danielsson-Tham ML, Peiris I, Helmersson S, Unemo M, Andersson B, Arneborn M, Bannerman E, Barbuddhe S, Bille J, Hajdu L, Jacquet C, Johansson C, Löfdahl M, Möllerberg G, Ringberg H, Rocourt J, Tjernberg I, Ursing J, Henriques-Normark B, Tham W.

Foodborne Pathog Dis. 2008 Dec;5(6):755-61. doi: 10.1089/fpd.2008.0123.

PMID:
18847381
22.

C6-peptide serology as diagnostic tool in neuroborreliosis.

Tjernberg I, Schön T, Ernerudh J, Wistedt AC, Forsberg P, Eliasson I.

APMIS. 2008 May;116(5):393-9. doi: 10.1111/j.1600-0463.2008.00842.x.

PMID:
18452429
23.

Clinical studies of acinetobacter classified By DNA-DNA hybridization. 1989.

Tjernberg I, Ursing J.

APMIS. 2007 May;115(5):646-56; discussion 657-8. No abstract available.

PMID:
17504430
24.

C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden.

Tjernberg I, Krüger G, Eliasson I.

Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):37-42.

PMID:
17180348
25.

Naturally transformable Acinetobacter sp. strain ADP1 belongs to the newly described species Acinetobacter baylyi.

Vaneechoutte M, Young DM, Ornston LN, De Baere T, Nemec A, Van Der Reijden T, Carr E, Tjernberg I, Dijkshoorn L.

Appl Environ Microbiol. 2006 Jan;72(1):932-6.

26.

Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L.

Int J Syst Evol Microbiol. 2001 Sep;51(Pt 5):1891-9.

PMID:
11594623
27.
28.

Oil-degrading Acinetobacter strain RAG-1 and strains described as 'Acinetobacter venetianus sp. nov.' belong to the same genomic species.

Vaneechoutte M, Tjernberg I, Baldi F, Pepi M, Fani R, Sullivan ER, van der Toorn J, Dijkshoorn L.

Res Microbiol. 1999 Jan-Feb;150(1):69-73.

PMID:
10096135
29.

Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species.

Dijkshoorn L, Van Harsselaar B, Tjernberg I, Bouvet PJ, Vaneechoutte M.

Syst Appl Microbiol. 1998 Mar;21(1):33-9.

PMID:
9786720
30.

Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.

Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M.

J Clin Microbiol. 1997 Nov;35(11):2819-25.

31.

Development of resistance to ciprofloxacin in Acinetobacter baumanii strains isolated during a 20-month outbreak.

Horrevorts A, ten Hagen G, Hekster Y, Tjernberg I, Dijkshoorn L.

J Antimicrob Chemother. 1997 Sep;40(3):460-1. No abstract available.

PMID:
9338509
32.

Discrimination of Acinetobacter genomic species by AFLP fingerprinting.

Janssen P, Maquelin K, Coopman R, Tjernberg I, Bouvet P, Kersters K, Dijkshoorn L.

Int J Syst Bacteriol. 1997 Oct;47(4):1179-87.

PMID:
9336926
33.

First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.

Melhus A, Tjernberg I.

Scand J Infect Dis. 1996;28(2):191-3. Review.

PMID:
8792490
34.

Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit.

Horrevorts A, Bergman K, Kollée L, Breuker I, Tjernberg I, Dijkshoorn L.

J Clin Microbiol. 1995 Jun;33(6):1567-72.

35.

Pillows, an unexpected source of Acinetobacter.

Weernink A, Severin WP, Tjernberg I, Dijkshoorn L.

J Hosp Infect. 1995 Mar;29(3):189-99.

PMID:
7615936
36.

First documented case of bacteremia with Vibrio vulnificus in Sweden.

Melhus A, Holmdahl T, Tjernberg I.

Scand J Infect Dis. 1995;27(1):81-2.

PMID:
7784822
37.

Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.

Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G.

J Clin Microbiol. 1995 Jan;33(1):11-5.

38.
39.

Numerical classification and identification of Acinetobacter genomic species.

Kämpfer P, Tjernberg I, Ursing J.

J Appl Bacteriol. 1993 Sep;75(3):259-68.

PMID:
8244904
40.

Endemic acinetobacter in intensive care units: epidemiology and clinical impact.

Dijkshoorn L, van Dalen R, van Ooyen A, Bijl D, Tjernberg I, Michel MF, Horrevorts AM.

J Clin Pathol. 1993 Jun;46(6):533-6.

41.

Reliability of phenotypic tests for identification of Acinetobacter species.

Gerner-Smidt P, Tjernberg I, Ursing J.

J Clin Microbiol. 1991 Feb;29(2):277-82.

42.

Lack of PQQ dependent glucose dehydrogenase apoenzyme in some Acinetobacter spp.

Gerner-Smidt P, Tjernberg I.

Antonie Van Leeuwenhoek. 1990 Aug;58(2):99-100.

PMID:
2176072
43.
44.

Clinical strains of Acinetobacter classified by DNA-DNA hybridization.

Tjernberg I, Ursing J.

APMIS. 1989 Jul;97(7):595-605.

PMID:
2751895

Supplemental Content

Loading ...
Support Center